A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers ...

The current diagnostic pathway for suspected prostate cancer in the United Kingdom involves either a high PSA level (>2.5 μg per liter in persons <50 years of age, >3.5 μg per liter in persons ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have ...

Typically, only 25 per cent of men with a high PSA level will actually have prostate cancer. But following an MRI and prostate biopsy, 187 (40 per cent) of the 468 men with a high PRS were ...

In 74 (71.8%) of these participants, cancer would not have been detected according to the diagnostic pathway currently used ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Researchers have found in a new canadian prospective cohort study that high sensitivity C-reactive protein (hsCRP) may serve ...

Discover the study that shows a new PRS spit test is more effective than the current UK prostate cancer screening pathway.